Adrenergic receptor

From Wikipedia, the free encyclopedia

The adrenergic receptors (or adrenoceptors) are a class of G protein-coupled receptors that are targets of the catecholamines. Adrenergic receptors specifically bind their endogenous ligands, the catecholamines adrenaline and noradrenaline (also called epinephrine and norepinephrine in the USA), and are activated by these.

Many cells possess these receptors, and the binding of an agonist will generally cause the cell to respond in a fight-or-flight manner. For instance, the heart rate will increase and the pupils will dilate, energy will be mobilized, and blood flow diverted from other organs to skeletal muscle.

Contents

[edit] Subtypes of adrenergic receptors

There are several types of adrenergic receptors, but there are two main groups: α-Adrenergic and β-Adrenergic.

  • α receptors bind norepinephrine and epinephrine, though norepinephrine has higher affinity. Phenylephrine is a selective agonist of the α receptor.
  • β receptors are linked to Gs proteins, which in turn are linked to adenylyl cyclase. Agonist binding thus causes a rise in the intracellular concentration of the second messenger cAMP. Downstream effectors of cAMP include cAMP-dependent protein kinase (PKA), which mediates some of the intracellular events following hormone binding.

[edit] Comparison

Receptor type Agonist potency order Location / Action Mechanism Agonists Antagonists
α1:
ADRA1A, ADRA1B, ADRA1D
noradrenaline≥ adrenaline >> isoprenaline Smooth muscle. In blood vessels the principal effect is vasoconstriction. Blood vessels with α1 receptors are present in the skin and the gastrointestinal system, and during the fight-or-flight response vasoconstriction results in the decreased blood flow to these organs. This accounts for an individual's skin appearing pale when frightened. In the GI tract, the effect is relaxation. Gq: phospholipase C (PLC) activated, IP3 and calcium up noradrenaline
phenylephrine
(Alpha blockers)
phenoxybenzamine
phentolamine
prazosin
tamsulosin
terazosin
α2:
ADRA2A, ADRA2B, ADRA2C
adrenaline > noradrenaline >> isoprenaline Pre- and postsynaptic nerve terminals. Mediates synaptic transmission. Gi: adenylate cyclase inactived, cAMP down clonidine
lofexidine
xylazine
(Alpha blockers)
yohimbine
β1:
ADRB1
isoprenaline > noradrenaline > adrenaline Heart and cerebral cortex. In heart, agonists enhance myocardial contractility and increase heart rate. Gs: adenylate cyclase actived, cAMP up noradrenaline
isoproterenol
dobutamine
(Beta blockers)
metoprolol
atenolol
β2:
ADRB2
isoprenaline > adrenaline > noradrenaline Lung, smooth muscle, cerebellum. In lung, agonists cause bronchiole dilation. Agonists can be useful in treating asthma. In smooth muscle, relaxes walls. Gs: adenylate cyclase actived, cAMP up (Short/long)
albuterol
bitolterol mesylate
formoterol
isoproterenol
levalbuterol
metaproterenol
salmeterol
terbutaline
(Beta blockers)
butoxamine
propranolol
β3:
ADRB3
isoprenaline > noradrenaline > adrenaline Adipose tissue. Agonists enhance lipolysis. Gs: adenylate cyclase actived, cAMP up L-796568 (Beta blockers)
SR 59230A

The absence of "ADRA1C" is intentional. At one time, there was a subtype known as C, but was found to be one of the previously discovered subtypes. To avoid confusion, it was decided that there would never be a C subtype again and so if any new subtypes were discovered, naming would start with E.

[edit] Diagrams

Labels in German, but most ideas can be understood. "Glatter" = "smooth", "hemmung" = "inhibition", "herzmuskels" = "heart muscle".
Labels in German, but most ideas can be understood. "Glatter" = "smooth", "hemmung" = "inhibition", "herzmuskels" = "heart muscle".
Epinephrin binds its receptor, that associates with an heterotrimeric G protein. The G protein associates with adenylate cyclase that converts ATP to cAMP, spreading the signal (more details...)
Epinephrin binds its receptor, that associates with an heterotrimeric G protein. The G protein associates with adenylate cyclase that converts ATP to cAMP, spreading the signal (more details...)


[edit] See also

[edit] References

  • Rang HP, Dale MM, Ritter JM, Moore PK (2003). "Ch. 11", Pharmacology. Elsevier Churchill Livingstone. ISBN 0-443-07145-4. 

[edit] External links


In other languages